The big Winners in just a span of 3 months. BRV just became a bagger
Column 1 Column 2 Column 3 Column 4 Column 5 Column 6 0 Featured Stocks Code Date Price In Today Chg% 1 Silver Mines SVL 18/05/20 $ 0.110 $ 0.260 136.36% 2 Investigator Resources (Silver Stock)(Meriam Gold & Silver Fund) IVR 18/05/20 $ 0.019 $ 0.058 205.26% 3 Pacifico Minerals (Silver Stock) PMY 21/05/20 $ 0.006 $ 0.026 333.33% 4 Big River Gold BRV 24/06/20 $ 0.031 $ 0.067 116.13% 5 Impact Minerals IPT 16/07/20 $ 0.016 $ 0.025 56.25% 6 Leroy Exploration LEX 16/07/20 $ 0.240 $ 0.340 41.67% 7 West Wits Mining WWI 16/07/20 $ 0.017 $ 0.025 47.06% 8 Adriatic Metals ADT 27/07/20 $ 1.970 $ 2.640 34.01%
..these ones remained relatively laggard
Column 1 Column 2 Column 3 Column 4 Column 5 Column 6 0 Featured Stocks Code Date Price In Today Chg% 1 Calidus Resources (Alkane) CAI 25/05/20 $ 0.385 $ 0.585 51.95% 2 De Grey Mining DEG 22/06/20 $ 0.640 $ 0.805 25.78% 3 Capricorn Metals CMM 25/05/20 $ 1.580 $ 1.950 23.42% 4 Bardoc Gold BDC 25/06/20 $ 0.081 $ 0.082 1.23% 5 Auteco Minerals (1832 Asset Mgt) AUT 3/07/20 $ 0.170 $ 0.210 23.53% 6 Resolution Minerals RML 20/07/20 $ 0.079 $ 0.071 -10.13% 7 RareX (Tolga K) REE 27/07/20 $ 0.065 $ 0.070 7.69% 8 Equus Mining (Palisades G) EQE 6/08/20 $ 0.015 $ 0.019 26.67% 9 Myanmar Metals MYL 10/08/20 $ 0.094 $ 0.105 11.70% 10 Firefly Resources (Tolga K) FFR 10/08/20 $ 0.100 $ 0.120 20.00% 11 Kalamazoo Resources (Sprott) KZR 11/08/20 $ 0.720 $ 0.730 1.39% 12 Austar Gold AUL 17/08/20 $ 0.325 $ 0.395 21.54% 13 Nelson Resources NES 19/08/20 $ 0.075 $ 0.075 0.00%
- Forums
- ASX - General
- Its Over
Its Over, page-5187
-
- There are more pages in this discussion • 17,614 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug